PHVS
Pharvaris N.V.NASDAQHealthcare$28.56-3.02%ClosedMarket Cap: $1.86B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
4.94
P/S
0.00
EV/EBITDA
-8.26
DCF Value
$5.95
FCF Yield
-8.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-67.1%
ROA
-49.0%
ROIC
-27.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2025 | $0.00 | NaN% | $-39.7M | $-37.1M | $-0.60 | — |
| Q2 2025 | $0.00 | NaN% | $-40.4M | $-45.5M | $-0.83 | — |
| Q1 2025 | $0.00 | NaN% | $42.2M | $-46.3M | $-0.85 | — |
| Q4 2024 | $0.00 | -Infinity% | $-48.1M | $-37.1M | $-0.64 | — |
| FY 2024 | $0.00 | NaN% | $-145.7M | $-134.2M | $-2.48 | — |
| Q3 2024 | $0.00 | NaN% | $-37.9M | $-41.7M | $-0.77 | — |
| Q2 2024 | $0.00 | NaN% | $-34.4M | $-29.7M | $-0.55 | — |
| Q1 2024 | $0.00 | NaN% | $-28.3M | $-28.0M | $-0.52 | — |
| Q4 2023 | $0.00 | -Infinity% | $-29.2M | $-35.2M | $-0.61 | — |
| FY 2023 | $0.00 | NaN% | $-96.9M | $-100.9M | $-2.63 | — |
| Q3 2023 | $0.00 | NaN% | $-26.2M | $-23.6M | $-0.58 | — |
| Q2 2023 | $0.00 | -Infinity% | $-24.4M | $-23.8M | $0.02 | — |